Lee AV - Search Results

1

Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer.

Basudan A, Priedigkeit N, Hartmaier RJ, Sokol ES, Bahreini A, Watters RJ, Boisen MM, Bhargava R, Weiss KR, Karsten MM, Denkert C, Blohmer JU, Leone JP, Hamilton RL, Brufsky AM, Elishaev E, Lucas PC, Lee AV, Oesterreich S. Basudan A, et al. Among authors: lee av. Mol Cancer Res. 2019 Feb;17(2):457-468. doi: 10.1158/1541-7786.MCR-18-0946. Epub 2018 Oct 24. Mol Cancer Res. 2019. PMID: 30355675 Free PMC article.

2

Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells.

Oesterreich S, Lee AV, Sullivan TM, Samuel SK, Davie JR, Fuqua SA. Oesterreich S, et al. Among authors: lee av. J Cell Biochem. 1997 Nov 1;67(2):275-86. J Cell Biochem. 1997. PMID: 9328833

3

HET/SAF-B overexpression causes growth arrest and multinuclearity and is associated with aneuploidy in human breast cancer.

Townson SM, Sullivan T, Zhang Q, Clark GM, Osborne CK, Lee AV, Oesterreich S. Townson SM, et al. Among authors: lee av. Clin Cancer Res. 2000 Sep;6(9):3788-96. Clin Cancer Res. 2000. PMID: 10999774

4

Inhibition of oestrogen receptor activity by the co-repressor HET/SAF-B is relieved by blockade of histone deacetylase activity.

Oesterreich S, Zhang QP, Lee AV. Oesterreich S, et al. Among authors: lee av. Eur J Cancer. 2000 Sep;36 Suppl 4:S43-4. doi: 10.1016/s0959-8049(00)00221-5. Eur J Cancer. 2000. PMID: 11056314 No abstract available.

5

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer.

Oesterreich S, Allredl DC, Mohsin SK, Zhang Q, Wong H, Lee AV, Osborne CK, O'Connell P. Oesterreich S, et al. Among authors: lee av. Br J Cancer. 2001 Feb;84(4):493-8. doi: 10.1054/bjoc.2000.1606. Br J Cancer. 2001. PMID: 11207044 Free PMC article.

6

Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.

Oesterreich S, Zhang P, Guler RL, Sun X, Curran EM, Welshons WV, Osborne CK, Lee AV. Oesterreich S, et al. Among authors: lee av. Cancer Res. 2001 Aug 1;61(15):5771-7. Cancer Res. 2001. PMID: 11479214

7

Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer.

Lee AV, Cui X, Oesterreich S. Lee AV, et al. Clin Cancer Res. 2001 Dec;7(12 Suppl):4429s-4435s; discussion 4411s-4412s. Clin Cancer Res. 2001. PMID: 11916236 Review.

8

Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.

Cui X, Zhang P, Deng W, Oesterreich S, Lu Y, Mills GB, Lee AV. Cui X, et al. Among authors: lee av. Mol Endocrinol. 2003 Apr;17(4):575-88. doi: 10.1210/me.2002-0318. Epub 2003 Jan 2. Mol Endocrinol. 2003. PMID: 12554765

9

Estrogen-mediated down-regulation of E-cadherin in breast cancer cells.

Oesterreich S, Deng W, Jiang S, Cui X, Ivanova M, Schiff R, Kang K, Hadsell DL, Behrens J, Lee AV. Oesterreich S, et al. Among authors: lee av. Cancer Res. 2003 Sep 1;63(17):5203-8. Cancer Res. 2003. PMID: 14500345

10

26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3-6 December 2003: update on preclinical and translational research.

Lee AV, Chamness G, Oesterreich S. Lee AV, et al. Breast Cancer Res. 2004 Jan 19;6(2):E10. doi: 10.1186/bcr758. Breast Cancer Res. 2004. PMID: 14979916 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters